1. Mangoceuticals, Inc. ($MGRX)
Mangoceuticals, Inc., known as MangoRx, made its public debut at the end of March. Like most IPOs in the stock market this year, it was a lackluster event that has seen share prices plummet. However, the latest action over the last two sessions may suggest more bullishness in the market.
Last week the company reported an update on its debut commercial on YouTube. The company is developing various men’s health and wellness products via a telemedicine platform. Its drug is branded “Mango” and focuses on things like erectile dysfunction. In the MangoRx update, CEO Jacob Cohen announced that the “initial virality” of its debut commercial “is a testament to the success in our marketing approach.”
This week, MGRX stock has upheld its recent bullish trading trend as shares retested the $2.
2. Nordic American Tankers Ltd ($NAT)
Shipping stocks have floated higher this year thanks to a mix of global economic developments. Nordic American is one of the penny stocks benefiting from the trend.
Nordic’s fleet consists of crude oil tankers. The state of the energy market right now has brought a bit more volatility to related stocks. In an update earlier this year, CEO Herbjorn Hansson explained why shippers could be in high demand:
Against this backdrop, NAT stock has continued climbing in the stock market this week. Monday’s action saw one of the most significant single-day moves in the last few weeks.
3. Aethlon Medical Inc. (AEMD)
Besides a big move during the first quarter, trading action has been relatively muted for Aethlon Medical over the last few months. Needless to say, that trend changed toward the end of last week. The company is the developer of its Hemopurifier, which is a blood filtration system. It has applications in cancer and certain infectious diseases. Aethlon was in the news during several major health outbreaks, including the monkeypox outbreak last year.
No recent updates have come from the company, although share prices may suggest other catalysts in play. Since last Wednesday, AEMD stock has surged from around $0.40 to highs of over $0.70. Something that may have become a topic of discussion is what might happen this earnings season. In its last update, Aethlon highlighted several initiatives that could be a source of speculation. Aethlon contracted with NAMSA, a medical technology CRO to direct an oncology study in Australia and the US.
4. Onconova Therapeutics Inc. (ONTX)
Onconova is a biotech company developing products for patients with cancer. Specifically, its pipeline is designed around anti-cancer agents for disrupting cellular pathways vital to cancer cell proliferation. Its proprietary narazaciclib is under evaluation in two separate trials. Its other candidate is rigosertib, which is being studied in combination with nivolumab in non-small cell lung cancer and as a monotherapy in squamous cell carcinoma.
Last week when ONTX stock exploded higher, news can play a significant role when it comes to sentiment. Onconova announced plans to present preclinical data on its narazaciclib at this month’s American Association for Cancer Research meeting. Analysts have also begun weighing in on ONTX stock. Last week, HC Wainwright upgraded Onconova to Buy and announced an $11 price target. That is significantly higher than current levels and represents a premium of more than 1,240% to recent price levels.
The momentum fueled by these recent events has continued to foster a bullish trend in the stock market this week.
5. Tingo Group ($TIO)
Shares of Tingo Group have quietly mounted a strong rally in 2023. Market action has recently picked up in a major way and has seen TIO stock reach fresh 52-week highs. The company focuses on financial technology and niches within this market, including agri-fintech. Its Tingo Mobile operates in Africa with a portfolio of products like a device-as-a-service smartphone. It began expanding internationally with farmers.
This week Tingo announced plans to present at the Taglich Brothers investment conference next week. CEO Darren Mercer will headline the presentation and host Q&A breakout sessions. In anticipation of this event, it looks like the market has noticed.
6. OLB Group ($OLB) is just under $1.00 with a market cap of only $14 Million. But they reported revenue of over $30 Million. As of April 21, 2023, OLB Group Inc had a $14.4 million market capitalization, putting it in the 14th percentile of companies in the Online Services industry.
A Fintech company with a Bitcoin mining subsidiary could easily trade at 2 times revenue--which would mean $3.00- $4.00/share. If Bitcoin runs again this week spinoff most likely attract more attention.
A buy signal was issued from a pivot bottom point on Friday, March 10, 2023, and so far it has risen 4.38%. Further rise is indicated until a new top pivot has been found.
The future price of the stock is predicted at $3.398 (+253.85%) after a year
This means that if you invested $100 now, your current investment may be worth $353.9 on April 2024.
No comments:
Post a Comment